NL · NL · NL-0d64c4f187df

Rifadin, capsules 150 mg

ATC J04AB02

Last synced from CBG-MEB (Netherlands) on June 9, 2026

Identification

ManufacturerSanofi B.V.

CountryNL (NL)

ATC codeJ04AB02

Dispensing—

ReimbursedNo

SourceCBG-MEB (Netherlands)

Last synced6/9/2026

Packs · 1

cbg_meb_id
05764

Annotations

No annotations yet.

Raw payload (JSON)

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h05764_smpc.pdf",
  "strength": null,
  "atc_label": "Rifampicin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg05764",
  "excipients": [
    "ERYTHROSINE (E 127)",
    "GELATINE (E 441)",
    "INDIGOKARMIJN (E 132)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "RIFAMPICINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h05764.pdf",
  "authorised_at": "1969/10/16",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "05764",
  "additional_monitoring": "N"
}

Related drugs

Other records sharing ATC code J04AB02.

Access this data programmatically

Query Rifadin, capsules 150 mg and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs